NEU 3.32% $20.52 neuren pharmaceuticals limited

Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m, page-8

  1. 24 Posts.
    lightbulb Created with Sketch. 14
    And that would be almost $60 million aust……OMG!!!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.